IS7019A - Crystalline form of 'R- (R *, R *) - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4-phenylamino) carbonyl] -1H-carboxylic acid pyrrole-1-heptanoic acid calcium salt (2: 1) (atorvastatin) - Google Patents

Crystalline form of 'R- (R *, R *) - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4-phenylamino) carbonyl] -1H-carboxylic acid pyrrole-1-heptanoic acid calcium salt (2: 1) (atorvastatin)

Info

Publication number
IS7019A
IS7019A IS7019A IS7019A IS7019A IS 7019 A IS7019 A IS 7019A IS 7019 A IS7019 A IS 7019A IS 7019 A IS7019 A IS 7019A IS 7019 A IS7019 A IS 7019A
Authority
IS
Iceland
Prior art keywords
atorvastatin
phenylamino
methylethyl
fluorophenyl
dihydroxy
Prior art date
Application number
IS7019A
Other languages
Icelandic (is)
Inventor
Robert Byrn Stephen
Andrew Coates David
Sue Gushurst Karen
Grant Morrison Ii Henry
Park Aeri
Ivanova Vlahova Petinka
Jane Li Zheng
Francis Krzyzaniak Joseph
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2002/001796 external-priority patent/WO2003004470A1/en
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of IS7019A publication Critical patent/IS7019A/en

Links

IS7019A 2002-05-21 2003-11-10 Crystalline form of 'R- (R *, R *) - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4-phenylamino) carbonyl] -1H-carboxylic acid pyrrole-1-heptanoic acid calcium salt (2: 1) (atorvastatin) IS7019A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/001796 WO2003004470A1 (en) 2001-06-29 2002-05-21 Crystalline forms of 'r-(r*,r*)!-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)

Publications (1)

Publication Number Publication Date
IS7019A true IS7019A (en) 2003-11-10

Family

ID=36700993

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7019A IS7019A (en) 2002-05-21 2003-11-10 Crystalline form of 'R- (R *, R *) - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4-phenylamino) carbonyl] -1H-carboxylic acid pyrrole-1-heptanoic acid calcium salt (2: 1) (atorvastatin)

Country Status (1)

Country Link
IS (1) IS7019A (en)

Similar Documents

Publication Publication Date Title
PL367943A1 (en) Crystalline forms of 'r-(r*,r*)!-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
ATE208375T1 (en) CRYSTALLINE (R-(R*,R*))-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-1H- PYRROLE-1-HEPTANCARBOXIC ACID HEMI CALCIUM SALT (ATORVASTATIN)
DK0839132T5 (en) Process for the preparation of amorphous [R- (R *, R *)] - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl ] -1H-pyrrole-1-heptanoic acid calcium salt (2: 1)
PL370061A1 (en) Crystalline (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-heptanoic acid calcium salt (2:1)
ATE207465T1 (en) CRYSTALLINE FORM III OF THE HEMI CALCIUM SALT OF (R-(R*,R*))-2-(4-FLUOROPHENYL)-BETA-DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (( PHENYLAMINO)CARBONYL)-1H-PYRROL-1-HEPTANIC ACID (ATORVASTATIN)
HUP0402590A3 (en) Method of manufacturing an amorphous form of the hemi-calcium salt of (3r,5r)7-3-phenyl-4-phenylcarbomoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl!-3, 5-dihydroxyheptanoic acid (atorvastatin)
BG108518A (en) Crystalline forms vi and vii of atorvastatin calcium
AU2000254249A1 (en) Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
DE60222687D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAIN MYCOPHENOLIC ACID OR A MYCOPHENOLATE SALT
EP2540704A3 (en) Benethamine salt forms of atorvastatin
AU2003297594A1 (en) Crystalline form f of atorvastatin hemi-calcium salt
IL173651A0 (en) Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
EP1963263A4 (en) POLYMORPHS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)- BETA,DELTA -DIHYDROXY-5-(L-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-lH-PYRROLE-l-HEPTANOIC ACID MAGNESIUM SALT (2: 1)
NO975499D0 (en) Form III Crystalline (R- (R *, R *) - 2 (4-Fluorophenyl) - <beta> - <title> -dihydroxy- (1-methyl-ethyl) -3-phenyl-4- (phenylamino) carbonyl) -1H-pyrrole-1-heptanoic acid hemi calcium salt
DK1957452T3 (en) Novel forms of [R- (R *, R *)] - 2- (4-fluorophenyl) -B, B-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl] - 1H-pyrrole-1-heptanoic acid magnesium
AU2001234058A1 (en) Form v crystalline (r-(r*,r*))-2-(4-fluorophenyl)-ss,$g(d)-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1- heptanoic acid hemi calcium salt. (atorvastatin)
AU2003278597A1 (en) (r-(r*,r*))-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-((1-methylethyl) -3-phenyl-4-((phenylamino) carbonyl)- 1h-pyrrole-1-heptanoic acid iron salt
PL349307A1 (en) Novel crystalline form of semi-calcium [r-(r ,r)]-2-(4-fluorophenyl)-beta, dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl)-1h-pyrrole-1-heptanic salt (athorovastatin), method of obtaining same, pharmacological composition containing such salt and medical application thereof
ZA200303974B (en) Hydrolysis of [R(R*,R*)]-2-(4-Fluorophenyl)-b,D-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic acid esters with calcium hydroxide.